News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

FDA approves Boehringer drug to treat advanced lung cancer

Started by riky, July 13, 2013, 09:00:19 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

FDA approves Boehringer drug to treat advanced lung cancer

<p><a href="http://news.yahoo.com/fda-approves-boehringer-drug-treat-advanced-lung-cancer-142657263.html"><img src="http://l.yimg.com/bt/api/res/1.2/AzCalg1.1Li4slhAoYjT7A--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-12T142657Z_1_CBRE96B145300_RTROPTP_2_CHINA-PHARMACEUTICALS.JPG" width="130" height="86" alt="A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring" align="left" title="A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring" border="0" /></a>(Reuters) - The U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are suffering from late stage non-small cell lung cancer and whose tumors express a specific type of gene mutation. The drug, Gilotrif, was approved along with a companion diagnostic kit that can help determine if a patient's lung cancer cells express the epidermal growth factor receptor (EGFR) gene mutation. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and represents about 85 percent of all lung cancers. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login